Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival

RT @OmiCure_AI: New algorithm aims to identify #transcriptomic predictors of #treatmentoutcomes. At OmiCure, we believe in tumor profiling…

New algorithm aims to identify #transcriptomic predictors of #treatmentoutcomes. At OmiCure, we believe in tumor profiling and genomic analysis to find the best treatment for advanced cancer. ➡️Full article : https://t.co/6sPMAPBUV3. #cancerfight #precis

RT @PrecisionOncIre: "Notwithstanding the small cohort and pending further prospective validation, the prototype of DDPP offers the potenti…

"Notwithstanding the small cohort and pending further prospective validation, the prototype of DDPP offers the potential to transform patients’ treatment selection with a tumor- & treatment-agnostic predictor of outcomes." #CancerResearch #OpenAccess #

"The expanding targeted therapy landscape requires combinatorial biomarkers for patient stratification & treatment selection. We present the algorithm DDPP, aiming to identify transcriptomic predictors of treatment outcome." #OpenAccess #PrecisionOncol

RT @Nature_NPJ: Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy an…

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival. #npjprecisiononcology https://t.co/rQVeW4R68B https://t.co/LaorjqYXiA

https://t.co/3auwpa1oiH

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival https://t.co/U3GBHttOVP

RT @BenWestphalen: Fascinating #research paper in @Nature_NPJ #PrecisionOncology @Vlad_Lazar_WIN & WINTHER team report on the Digital Disp…

RT @BenWestphalen: Fascinating #research paper in @Nature_NPJ #PrecisionOncology @Vlad_Lazar_WIN & WINTHER team report on the Digital Disp…

Fascinating #research paper in @Nature_NPJ #PrecisionOncology @Vlad_Lazar_WIN & WINTHER team report on the Digital Display Precision Predictor identifying transcriptomic predictors of tx outcome. @OncoAlert 🚨 @Dr_R_Kurzrock #PrecisionMedicine https

2/3 癌腫も薬剤も横断でのPFS予測はすごいかも Solidな検証が待たれる エベロリムス(mTOR阻害剤)、アキシチニブ(VEGFR受容体阻害剤)、アファチニブ(Pan-HER阻害剤)、トラメチニブ(MEK阻害剤)、FGFR阻害剤、抗PD-1 / PDL-1抗体(ペンブロリズマブ、ニボルマブ、アテゾリズマブ) https://t.co/4vJP2G0kEH

1/3 標的療法と無増悪生存期間の予測するグローバルバイオマーカーモデルのプロトタイプ /npj precision oncology https://t.co/4vJP2G0kEH WINTHER試験の各薬剤のPFSデータと腫瘍・正常組織のトランスクプリトームデータから多種薬剤の予測モデルを作成、少数例ですがよく予測できている

Discover the background to Lazar V. et al. latest paper on Digital Display Precision Predictor: the prototype of a global biomarker... "Behind the Paper" published in Nature Community https://t.co/J14ZnKk9Ec @WIN_Consortium @SpringerNature @Nature_NPJ h

@WIN_Consortium #research #cancer global biomarker prototype to guide targeted therapy choice and predict response duration featured in @GenomeWeb https://t.co/KX1nG3IQWE     Read paper: @SpringerNature in @Nature_NPJ precision oncology https://t.co/yQR9aX

Digital Display Precision Predictor: the prototype of a global biomarker model to guide treatments with targeted therapy and predict progression-free survival https://t.co/YBoqyoK5WU #hvhebron #onco [Text complet]

@WIN_Consortium latest #research on #cancer global biomarker prototype to guide targeted therapy choice and predict response duration, published with @SpringerNature in @Nature_NPJ precision oncology. Read here: https://t.co/OEWUnBQK7D

RT @WIN_Consortium: @WIN_Consortium latest #research on #cancer global biomarker prototype to guide targeted therapy & predict response dur…

RT @WIN_Consortium: @WIN_Consortium latest #research on #cancer global biomarker prototype to guide targeted therapy & predict response dur…

@WIN_Consortium latest #research on #cancer global biomarker prototype to guide targeted therapy & predict response duration, published with @SpringerNature in @Nature_NPJ precision oncology. https://t.co/yQR9aXkWFL